Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-8338

Single-particle
30.0 Å
EMD-8338
3D View Gallery
Deposition: 16/08/2016
Map released: 26/10/2016
Last modified: 30/08/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-8338
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

HCV E2 bound to AR1B, AR2A, and HCV1 Fabs

EMD-8338

Single-particle
30.0 Å
EMD-8338
3D View Gallery
Deposition: 16/08/2016
Map released: 26/10/2016
Last modified: 30/08/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Hepatitis C virus, Homo sapiens
Sample: HCV E2 bound to 3 different neutralizing fragments antigen binding (Fabs)

Deposition Authors: Ward AB, Nieusma T
Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
Kong L , Lee DE, Kadam RU, Liu T, Giang E, Nieusma T, Garces F, Tzarum N , Woods VL, Ward AB, Li S, Wilson IA, Law M
(2016) PNAS
PUBMED: 27791120
DOI: doi:10.1073/pnas.1609780113
ISSN: 1091-6490
ASTM: PNASA6